Investors
Guidance for 2023
Guidance for 2023 was last updated in connection of Q1/2023 result on 28 April 2023.
Terveystalo estimates its revenue for the full year 2023 to grow (2022: EUR 1,259 million) and its adjusted EBITA margin to be between 9.1 % and 10.1 %.
Estimates are based on consumer demand and the number of employed remaining on current levels both in Finland and Sweden, the profit improvement program delivering a 30-million-euro P&L impact in 2023, and moderate inflation during 2023. Additionally, the estimates assume no material changes in public sector behaviour, excluding the reduction of public outsourcing revenue from 2022 levels. Estimates exclude any material acquisitions or divestments.